ADAR1 CAPITAL MANAGEMENT, LLC purchased 141.4% of their position (468.55K shares) of INMED PHARMACEUTICALS INC. on the open market
Open‑market purchase worth $721.5K — a major conviction buy. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 5/21/2026ACC: 0001940272-26-000008
10% Owner
Since May 2026
+468.55K
Net shares
Net buyer
$721.5K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
468.55K acquired
Non-Derivative Transactions3
Common Shares
Indirect
Shares
+68.55K
Price / share
$1.60
Trade value
$109.67K
% of position
20.7%
5/19/2026
331.45K→400K
Common Shares
Indirect
Shares
+200K
Price / share
$1.56
Trade value
$312.08K
% of position
50.0%
5/19/2026
400K→600K
Common Shares
Indirect
Shares
+200K
Price / share
$1.50
Trade value
$299.80K
% of position
33.3%
5/19/2026
600K→800K
Total
Net shares
+468.55K
Net value
$721.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Indirect | 5/19/2026 | P · Purchase | +68.55K | $1.60 | $109.67K | 20.7% | 331.45K | 400K |
| Common Shares Indirect | 5/19/2026 | P · Purchase | +200K | $1.56 | $312.08K | 50.0% | 400K | 600K |
| Common Shares Indirect | 5/19/2026 | P · Purchase | +200K | $1.50 | $299.80K | 33.3% | 600K | 800K |
| Total | +468.55K | $721.55K | ||||||
Derivative Transactions0
No derivative transactions reported